✦ LIBER ✦

AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression

✍ Scribed by Tian, Yuantong; Zhao, Lijing; Zhang, Haitao; Liu, Xichun; Zhao, Lijuan; Zhao, Xuejian; Li, Yi; Li, Jing

Book ID: 125402433
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 459 KB
Volume: 9
Category: Article
ISSN: 1746-1596
DOI: 10.1186/1746-1596-9-42

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Syndecan-1 expression in prostate cancer

Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression

✍ Fadi Brimo; Robin T. Vollmer; Matthew Friszt; Jacques Corcos; Tarek A. Bismar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB

2238 ERG AS A POTENTIAL BIOMARKER FOR PR

2238 ERG AS A POTENTIAL BIOMARKER FOR PROSTATE CANCER MAY BENEFIT EUROPEAN AMERICAN MEN BUT NOT AFRICAN AMERICAN MEN

✍ Powell, Isaac; Dyson, Greg; Bollig-Fischer, Aliccia 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

861 SERUM ALKALINE PHOSPHATASE AS A BIOM

861 SERUM ALKALINE PHOSPHATASE AS A BIOMARKER FOR DIFFERENTIATING PROSTATE-SPECIFIC ANTIGEN SURGE PHENOMENON FROM PROGRESSION IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE CANCER RECEIVING SYSTEMIC CHEMOTHERAPY

✍ Han, Kyung Seok; Ham, Won Sik; Lee, Young Hoon; Han, Woong Kyu; Rha, Koon Ho; Ch 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

Metabolism of N-[4-hydroxyphenyl]retinam

Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells

✍ R.R. Mehta; M.E. Hawthorne; J.M. Graves; R.G. Mehta 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 131 KB